ÇÑ×ÓÖ±²¥

Amer Assal, MD

Hematology/Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • EPO
  • HMO
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

I am a hematologist and medical oncologist who specializes in the care of patients who need a bone marrow transplant (BMT) or cellular therapy (such as chimeric antigen receptor or “CAR” T-cell treatment). Bone marrow transplant, also known as hematopoietic stem cell transplant, is when blood forming stem cells are transplanted using the patients’ own cell, donor cells, or saved umbilical cord blood. These treatments are used for cancerous (malignant) or non-cancerous but serious medical conditions. These include leukemias (acute myeloid leukemia, chronic myeloid leukemia, acute lymphocytic leukemia, chronic lymphocytic leukemia), lymphomas, multiple myeloma, myelofibrosis, myeloproliferative neoplasms, myelodysplastic syndromes, aplastic anemia, among others. A diagnosis with any of these conditions is daunting and can leave patients feeling very anxious, vulnerable, and unsure of what to expect and what to do. I strive to build an empathic connection with my patients where their questions are answered, their fears are alleviated, and in which they can fully understand their condition and what the best treatment options are for them. My colleagues and I strive to deliver treatment options that are on the forefront of medical research. As part of a multidisciplinary team, we all strive to deliver a comprehensive assessment and treatment plan for each patient. My research interests focus on the prevention and treatment of complications following BMT and CAR T cell therapies. My goal is to bring the latest advancements in medicine to my patients. As a New York City-native and CUNY alumnus, I am also passionate about equitable access to care, and ensuring all communities of the NYC metropolitan area, especially underserved communities and those with unmet needs, can get access to care and to the cutting edge cancer treatments that we have available at ÇÑ×ÓÖ±²¥ and NewYork-Presbyterian Hospital.

Biographical Info

Amer Assal, MD is an Associate Professor of Medicine in the Division of Hematology and Medical Oncology at ÇÑ×ÓÖ±²¥ and NewYork-Presbyterian Hospital where he is part of the Bone Marrow Transplant and Cellular Therapy Program. After earning his BA in Biological Sciences and Philosophy at Lehman College of the City University of New York, Dr. Assal received his medical degree from New York University (NYU) School of Medicine, where he also completed his internship and residency in Internal Medicine. Dr. Assal then completed his fellowship in Hematology and Medical Oncology at Albert Einstein College of Medicine-Montefiore Medical Center where has was elected as Chief Fellow. Following his training in hematology and oncology, Dr. Assal completed an advanced fellowship in hematopoietic stem cell transplantation at Memorial Sloan Kettering Cancer Center. Upon completion of his training, Dr. Assal joined the NewYork-Presbyterian Columbia University Irving Medical Center as Assistant Professor of Medicine, as part of the Blood and Marrow Transplant Program. He was later recruited as Associate Professor of Medicine to Rutgers Cancer Institute of New Jersey. His research interests include developing novel approaches to prevent and treat graft-versus-host disease (GVHD) which can be a serious complication of bone marrow transplant. Dr. Assal also has an interest in the treatment and prevention of cytokine release syndrome which can be a serious complication of CAR T cell therapies. He has published in several leading peer-reviewed journals and is a member of the American Society for Transplantation and Cellular Therapy (ASTCT) and the American Society of Hematology (ASH).

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology)
Research
Education 
  • M.D.
    New York University School of Medicine
    2008
  • B.A.
    City College, City University of New York
    2004
Appointments 
  • Associate Attending Physician
    NewYork-Presbyterian Hospital
  • Associate Professor of Medicine (Pending Appointment at Rank)
    ÇÑ×ÓÖ±²¥ Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported